Does ASPIRIN Cause Vascular access site complication? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Vascular access site complication have been filed in association with ASPIRIN (Aspirin). This represents 0.0% of all adverse event reports for ASPIRIN.
5
Reports of Vascular access site complication with ASPIRIN
0.0%
of all ASPIRIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Vascular access site complication From ASPIRIN?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Vascular access site complication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ASPIRIN Cause?
Gastrointestinal haemorrhage (13,172)
Anaemia (4,568)
Off label use (4,283)
Dyspnoea (4,280)
Drug hypersensitivity (4,072)
Drug ineffective (4,061)
Upper gastrointestinal haemorrhage (3,411)
Epistaxis (3,214)
Rectal haemorrhage (3,057)
Acute kidney injury (2,976)
What Other Drugs Cause Vascular access site complication?
CONESTAT ALFA (90)
HUMAN C1-ESTERASE INHIBITOR (74)
PEMBROLIZUMAB (14)
CARBOPLATIN (8)
PEMETREXED (7)
CLOPIDOGREL BISULFATE (5)
Which ASPIRIN Alternatives Have Lower Vascular access site complication Risk?
ASPIRIN vs ASPIRIN DL-LYSINE
ASPIRIN vs ASPIRIN LYSINE
ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE
ASPIRIN vs ASPIRIN\CAFFEINE
ASPIRIN vs ASPIRIN\CARISOPRODOL